MedRegulus

The computed 12-month bankruptcy probability of MedRegulus is 1.6% (moderate). The 2025 annual accounts show negative equity (-€256,512) and a net result of -€9,117. Equity is shrinking by about 48% per year across the filed financial years. Its solvency ranks better than 5% of 1,120 sector peers (NACE 77, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.